Ligand Pharmaceuticals reported $6.39M in Interest Income for its fiscal quarter ending in December of 2025.





Interest Income Change Date
Arrowhead Research USD 9.69M 637K Dec/2025
Baxter International USD 11M 1000K Dec/2025
Eli Lilly USD 65M 25M Sep/2025
Enviri Corporation USD -1.05 0.89 Dec/2024
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
Glaxosmithkline GBP 26M 24M Sep/2025
Heron Therapeutics USD 433K 277K Dec/2021
Insmed USD 765K 55K Sep/2024
Intrexon USD 319K 602K Jun/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Ligand Pharmaceuticals USD 6.39M 2.52M Dec/2025
MacroGenics USD 1.53M 114K Sep/2025
Merck USD 69M 27M Dec/2025
Pacira USD 2.3M 6.24M Dec/2025
Pfizer USD 115M 51M Mar/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Veracyte USD 3.48M 545K Sep/2025